These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 21942249)
1. The paradox of respiratory R&D, and why 'inhaled-by-design' heralds a new dawn in asthma and chronic obstructive pulmonary disease treatments. Yeadon M Future Med Chem; 2011 Oct; 3(13):1581-3. PubMed ID: 21942249 [No Abstract] [Full Text] [Related]
2. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy. Onoue S; Misaka S; Kawabata Y; Yamada S Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334 [TBL] [Abstract][Full Text] [Related]
3. Changes in inhaler devices for asthma and COPD. Capriotti T Medsurg Nurs; 2005 Jun; 14(3):185-94. PubMed ID: 16035636 [No Abstract] [Full Text] [Related]
8. [Combination therapy with inhaled bronchodilators in chronic obstructive pulmonary disease]. Shen N; Cai BQ; Yao WZ Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):766-7. PubMed ID: 19080604 [No Abstract] [Full Text] [Related]
9. Effects of inhaled therapies on health-related quality of life in stable chronic obstructive pulmonary disease. Antoniu SA Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):155-62. PubMed ID: 20384562 [TBL] [Abstract][Full Text] [Related]
10. [Development of theophylline in treatment of asthma and chronic obstructive pulmonary disease]. Xu YJ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):319-22. PubMed ID: 15266839 [TBL] [Abstract][Full Text] [Related]
12. Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat soft mist inhaler. Hodder R; Pavia D; Dewberry H; Alexander K; Iacono P; Ponitz H; Beck E Respir Med; 2005 Sep; 99(9):1087-95. PubMed ID: 15893465 [TBL] [Abstract][Full Text] [Related]
13. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance? Restrepo RD Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384 [TBL] [Abstract][Full Text] [Related]
14. Which treatment for obstructive airway disease: The inhaled bronchodilators. Perrotta F; Mazzeo F; Cerqua FS Pulm Pharmacol Ther; 2017 Apr; 43():57-59. PubMed ID: 28089891 [No Abstract] [Full Text] [Related]
15. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme. den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745 [TBL] [Abstract][Full Text] [Related]
16. Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient. Lessard A; Maltais F; Boulet LP Expert Opin Pharmacother; 2008 Jan; 9(1):83-93. PubMed ID: 18076340 [TBL] [Abstract][Full Text] [Related]
17. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease. Dalonzo GE J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593 [TBL] [Abstract][Full Text] [Related]
18. [Tiotropium: new about known]. Stepanian IE Ter Arkh; 2008; 80(3):82-4. PubMed ID: 18441692 [No Abstract] [Full Text] [Related]
19. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations]. MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494604 [No Abstract] [Full Text] [Related]
20. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD]. Henriet AC; Marchand-Adam S; Mankikian J; Diot P Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]